Dragenopharm Apotheker Pueschl GmbH

What Dragenopharm Apotheker Pueschl GmbH does

Aenova Group, operating through its legal entity Aenova Holding GmbH (HRB 200013, registered at Munich district court), is a privately held pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Starnberg (Percha), Germany. The company self-describes as a "worldwide leading contract manufacturer" for the pharmaceutical and healthcare industry and operates across three business segments: pharmaceutical manufacturing, development & technology, and animal health. Its core technology is pharmaceutical contract development and manufacturing services, including sterile technologies through a dedicated competence center in Latina, Italy, with managing directors Jan Kengelbach and Dr. Peter Waller overseeing operations.

The company's go-to-market is B2B-direct to pharmaceutical and healthcare customers, with no publicly disclosed pricing or contract structure. Distribution is implied to operate through direct sales relationships with pharmaceutical companies. Marketing and customer engagement leverage a corporate website, a bi-monthly newsletter providing updates on CDMO services and market trends, and corporate social profiles on LinkedIn, Instagram, and Facebook. Geographic reach is claimed worldwide, with no specific market restrictions documented in the source data.

Ownership is privately held with no disclosed external investors or parent company. The company maintains an investor-relations posture, evidenced by the publication of an Annual Report 2025 (referenced July 2026). Recent operational signals include a new Managing Director appointment at the Latina sterile facility (June 2026) and a silver medal in the EcoVadis sustainability rating (June 2026), indicating active management and ESG positioning. No revenue, headcount, funding-round, M&A, partnership, patent, or certification data is disclosed in the available sources. Note: the query references "Dragenopharm Apotheker Pueschl GmbH," but the substantive data pertains to Aenova Group / Aenova Holding GmbH; no source evidence confirms Dragenopharm's specific relationship to Aenova in this dataset.

Name

Dragenopharm Apotheker Pueschl GmbH

Legal name

Aenova Holding GmbH

Website

https://dragenopharm.de

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Aenova Group is a privately held, Germany-headquartered pharmaceutical CDMO offering contract manufacturing, development and technology services, and animal health solutions to pharmaceutical and healthcare customers worldwide.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industries

Small-Molecule API & Intermediates CDMO (HLAGABAA), Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Pharmaceutical contract manufacturing
• CDMO services
• Drug development
• Sterile manufacturing
• Animal health manufacturing

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure

Marketing channels5 records

Core offering

Dragenopharm Apotheker Pueschl GmbH provides contract development and manufacturing organization (CDMO) services for the pharmaceutical and healthcare industry. Its offerings span three business areas: Pharmaceutical Manufacturing, Development & Technology, and Animal Health — covering the production of human and veterinary drug products on behalf of clients. The company operates as part of the Aenova Group, which is positioned as a worldwide leading contract manufacturer in this field.

Product overview

The source data pertains to Aenova Group (a worldwide leading contract manufacturer for the pharmaceutical and healthcare industry), not Dragenopharm Apotheker Pueschl GmbH. Aenova Group offers pharmaceutical manufacturing, development and technology services, and animal health solutions as a CDMO (Contract Development and Manufacturing Organization).

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Manufacturing Contract manufacturing services for pharmaceutical drug products, covering production of human pharmaceuticals on behalf of clients within the Aenova Group network.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights4 records

Direct peers

• Hovione: Portuguese CDMO specialising in API development and manufacturing plus drug product services. Comparable to Aenova in contract development and manufacturing for the pharmaceutical industry, with overlapping capabilities in integrated services.
• Recipharm: Swedish CDMO offering pharmaceutical formulation, manufacturing, and development services across multiple dosage forms. Direct competitor to Aenova in European CDMO services for human and veterinary pharma.
• Lonza Group: Swiss-headquartered global CDMO leader offering integrated drug substance and drug product services across small molecules, biologics, and cell & gene therapies. Directly comparable to Aenova as a full-service pharmaceutical contract manufacturer serving large pharma customers worldwide.
• Fareva: French privately-held CDMO with broad pharmaceutical, cosmetic, and industrial manufacturing capabilities. Comparable to Aenova as a privately held European CDMO offering integrated contract manufacturing across multiple dosage forms.
• Almac Group: Northern Ireland-headquartered CDMO providing pharmaceutical development, manufacturing, and clinical trial supply services. Comparable to Aenova as a privately held, integrated CDMO with overlapping services across drug substance and drug product.
• Cambrex: US-headquartered CDMO providing small-molecule API and finished dosage form development and manufacturing services. Comparable to Aenova in contract pharmaceutical development and manufacturing for the pharma industry.
• WuXi STA (WuXi AppTec): China-based global CDMO offering API and drug product services across small molecules. Direct competitor to Aenova for outsourced pharma manufacturing with a meaningfully lower cost base and rapidly expanding global capacity.
• Siegfried Holding: Swiss CDMO specialising in API and finished drug products (including sterile). Comparable to Aenova as a European-headquartered, vertically integrated small-molecule CDMO with overlapping customer base and capabilities.
• Catalent: US-headquartered CDMO with strong oral solid dose, sterile fill-finish, and biologics capabilities. Directly comparable to Aenova's integrated pharmaceutical manufacturing and development offering across human pharma dosage forms.

Broad incumbents

• Patheon (Thermo Fisher Scientific): Patheon (now part of Thermo Fisher's pharma services segment) is one of the largest global CDMOs. Comparable as an integrated drug substance/drug product CDMO serving the same large-pharma customer base as Aenova, though operating at much greater scale within a broader life-sciences portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/aenovagroup
• LinkedInlinkedin.com/company/dragenopharm-apotheker-pueschl-gmbh
• Instagraminstagram.com/aenova_group

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dragenopharm Apotheker Pueschl GmbH